Historical salary details - Mr. Timothy P. Coughlin, Independent Director, Travere Therapeutics Inc
Mr. Timothy P. Coughlin is the Independent Director of Travere Therapeutics Inc. They also hold 2 other positions in Atyr Pharma Inc and Fate Therapeutics Inc.
Mr. Timothy P. Coughlin
Independent Director
$ 384.2 K
Gross Remuneration
-
Current Company
Travere Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Travere Therapeutics Inc | Independent Director | 254.8 K | - |
| 2024 | Atyr Pharma Inc | Chairman of the Board | 129.4 K | 40.3 % |
| 2024 | Fate Therapeutics Inc | Independent Director | - | - |
| 2023 | Fate Therapeutics Inc | Independent Director | 231.8 K | - |
| 2023 | Atyr Pharma Inc | - | 92.2 K | -4.2 % |
| 2023 | Travere Therapeutics Inc | Independent Director | - | - |
| 2023 | Fate Therapeutics Inc | Independent Director | - | - |
| 2022 | Travere Therapeutics Inc | Independent Director | 334.1 K | 12.6 % |
| 2022 | Atyr Pharma Inc | Independent Director | 96.2 K | 34.1 % |
| 2022 | Fate Therapeutics Inc | Independent Director | - | - |
| 2021 | Fate Therapeutics Inc | Independent Director | 445.5 K | 30.6 % |
| 2021 | Travere Therapeutics Inc | Independent Director | 296.7 K | 13.0 % |
| 2021 | Atyr Pharma Inc | Independent Director | 71.7 K | 0.1 % |
| 2020 | Fate Therapeutics Inc | Independent Director | 341.1 K | 35.9 % |
| 2020 | Travere Therapeutics Inc | Independent Director | 262.7 K | 2.7 % |
| 2020 | Atyr Pharma Inc | Independent Director | 71.7 K | -6.2 % |
| 2019 | Travere Therapeutics Inc | Independent Director | 255.7 K | -36.7 % |
| 2019 | Fate Therapeutics Inc | Independent Director | 250.9 K | 54.1 % |
| 2019 | Atyr Pharma Inc | Independent Director | 76.4 K | -17.0 % |
| 2018 | Travere Therapeutics Inc | Independent Director | 404 K | 78.2 % |
| 2018 | Fate Therapeutics Inc | Independent Director | 162.8 K | 14.5 % |
| 2018 | Atyr Pharma Inc | Independent Director | 92.1 K | -50.9 % |
| 2017 | Travere Therapeutics Inc | Independent Director | 226.7 K | 24.9 % |
| 2017 | Atyr Pharma Inc | Independent Director | 187.7 K | - |
| 2017 | Fate Therapeutics Inc | Independent Director | 142.2 K | 70.7 % |
| 2016 | Travere Therapeutics Inc | Independent Director | 181.5 K | -84.8 % |
| 2016 | Fate Therapeutics Inc | Independent Director | 83.3 K | -18.6 % |
| 2015 | Travere Therapeutics Inc | Independent Director | 1.2 M | - |
| 2015 | Fate Therapeutics Inc | Independent Director | 102.2 K | -2.6 % |
| 2014 | Fate Therapeutics Inc | Independent Director | 105.0 K | -30.0 % |
| 2014 | Travere Therapeutics Inc | Independent Director | - | - |
| 2013 | Fate Therapeutics Inc | Independent Director | 149.9 K | - |
| 2012 | Fate Therapeutics Inc | Independent Director | - | - |